The Structure of JNK3 in Complex with Small Molecule Inhibitors

[20] Processing of X-ray diffraction data collected in oscillation mode

Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475

Crystallography & NMR System: A New Software Suite for Macromolecular Structure Determination

Brünger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse‐Kunstleve, R. W., Jiang, J., Kuszewski, J. J., Nilges, M., Pannu, N., et al. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998003254 · Cited by 15,723

Improved methods for building protein models in electron density maps and the location of errors in these models

Jones, T. A., Zou, J.-Y., Cowan, S. W., & Kjeldgaard, M. (1991) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767390010224 · Cited by 12,616

Mammalian MAP kinase signalling cascades

Chang, L., & Karin, M. (2001) · Nature · doi:10.1038/35065000 · Cited by 5,118

AMoRe: an automated package for molecular replacement

Navaza, J. (1994) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767393007597 · Cited by 4,941

Crystallographic Computing 6

Flack, H. D., Párkányi, L., & Simon, K. (1993) · doi:10.1093/oso/9780198557883.001.0001 · Cited by 2,003

Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase

Schindler, T. H., Bornmann, W. G., Pellicena, P., Miller, W. T., Clarkson, B., & Kuriyan, J. (2000) · Science · doi:10.1126/science.289.5486.1938 · Cited by 1,785

Selective interaction of JNK protein kinase isoforms with transcription factors.

Gupta, S., Barrett, T., Whitmarsh, A. J., Cavanagh, J., Sluss, H. K., Dérijard, B., & Davis, R. J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00636.x · Cited by 1,341

Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 gene

Yang, D. D., Kuan, C.-Y., Whitmarsh, A. J., Rinócn, M., Zheng, T. S., Davis, R. J., RAKIC, P. T., & Flavell, R. A. (1997) · Nature · doi:10.1038/39899 · Cited by 1,230

Structures of the Tyrosine Kinase Domain of Fibroblast Growth Factor Receptor in Complex with Inhibitors

Mohammadi, M., McMahon, G., Sun, L., Tang, C., Hirth, P., Yeh, B. K., Hubbard, S. R., & Schlessinger, J. (1997) · Science · doi:10.1126/science.276.5314.955 · Cited by 1,099

Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis.

Estus, S., Zaks, W. J., Freeman, R. S., Gruda, M. C., Bravo, R., & Johnson, E. M. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.127.6.1717 · Cited by 820

c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis

Han, Z., Boyle, D. L., Chang, L., Bennett, B. L., Karin, M., Yang, L., Manning, A. M., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12466 · Cited by 797

A c-jun dominant negative mutant protects sympathetic neurons against programmed cell death

Ham, J., Babij, C., Whitfield, J. R., Pfarr, C. M., Lallemand, D., Yaniv, M., & Rubin, L. L. (1995) · Neuron · doi:10.1016/0896-6273(95)90331-3 · Cited by 795

JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation.

Kallunki, T., Su, B., Tsigelny, I., Sluss, H. K., Dérijard, B., Moore, G., Davis, R., & Karin, M. (1994) · Genes & Development · doi:10.1101/gad.8.24.2996 · Cited by 642

[25] Ribbons

Carson, M. (1997) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(97)77027-7 · Cited by 510

[10] Electron-density map interpretation

Jones, T. A., & Kjeldgaard, M. (1997) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(97)77012-5 · Cited by 507

Structural basis of inhibitor selectivity in MAP kinases

Wang, Z., Canagarajah, B. J., Boehm, J. C., Kassisà, S., Cobb, M. H., Young, P. R., Abdel‐Meguid, S. S., Adams, J. L., & Goldsmith, E. J. (1998) · Structure · doi:10.1016/s0969-2126(98)00113-0 · Cited by 429

Torsion angle dynamics: Reduced variable conformational sampling enhances crystallographic structure refinement

Rice, L. M., & Brünger, A. T. (1994) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.340190403 · Cited by 369

Chemical Inhibitors of Protein Kinases

Bridges, A. J. (2001) · Chemical Reviews · doi:10.1021/cr000250y · Cited by 324

Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution

Eyers, P. A., Craxton, M., Morricel, N., Cohen, P., & Goedert, M. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90170-3 · Cited by 310

The structural basis for the specificity of pyridinylimidazole inhibitors of p38 MAP kinase

Wilson, K. P., McCaffrey, P. G., Hsiao, K., Pazhanisamy, S., Galullo, V., Bemis, G. W., Fitzgibbon, M. J., Caron, P. R., Murcko, M. A., & Su, M. S. S. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90194-0 · Cited by 275

CEP-1347/KT-7515, an Inhibitor of c-jun N-Terminal Kinase Activation, Attenuates the 1-Methyl-4-Phenyl Tetrahydropyridine-Mediated Loss of Nigrostriatal Dopaminergic Neurons In Vivo

Saporito, M. S., Brown, E. M., Miller, M. S., & Carswell, S. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37972-8 · Cited by 266

Structural analysis of the lymphocyte-specific kinase Lck in complex with non-selective and Src family selective kinase inhibitors

Zhu, X., Kim, J. L., Newcomb, J. R., Rose, P., Stover, D. R., Toledo, L. M., Zhao, H., & Morgenstern, K. A. (1999) · Structure · doi:10.1016/s0969-2126(99)80086-0 · Cited by 257

Gene transfer of the JNK interacting protein-1 protects dopaminergic neurons in the MPTP model of Parkinson's disease

Xia, X., Harding, T. A., Weller, M., Bieneman, A., Uney, J. B., & Schulz, J. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181182298 · Cited by 230

p493F12 kinase: A novel MAP kinase expressed in a subset of neurons in the human nervous system

Mohit, A. A., Martin, J. H., & Miller, C. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90241-4 · Cited by 206

Crystal structure of JNK3: a kinase implicated in neuronal apoptosis

Xie, X., Gu, Y., Fox, T., Coll, J. T., Fleming, M. A., Markland, W., Caron, P. R., Wilson, K. P., & Su, M. S.-S. (1998) · Structure · doi:10.1016/s0969-2126(98)00100-2 · Cited by 198

Design and Synthesis of Potent, Selective, and Orally Bioavailable Tetrasubstituted Imidazole Inhibitors of p38 Mitogen-Activated Protein Kinase

Liverton, N. J., Butcher, J. W., Claiborne, C. F., Claremon, D. A., Libby, B. E., Nguyen, K. T., Pitzenberger, S. M., Selnick, H. G., Smith, G. R., Tebben, A. J., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9805236 · Cited by 197

Mechanism-based design of a protein kinase inhibitor.

Hubbard, S. R., Cole, P. A., Parang, K., Till, J. H., Ablooglu, A. J., & Kohanski, R. A. (2001) · Nature Structural Biology · doi:10.1038/83028 · Cited by 192

CEP‐1347 (KT7515), an Inhibitor of JNK Activation, Rescues Sympathetic Neurons and Neuronally Differentiated PC12 Cells from Death Evoked by three Distinct Insults

Maroney, A. C., Finn, J. P., Bozyczko‐Coyne, D., O’Kane, T. M., Neff, N. T., Tolkovsky, A. M., Park, D. S., Yan, C. Y. I., Troy, C. M., & Greene, L. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.01901.x · Cited by 190

Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity

Fitzgerald, C. E., Patel, S. B., Becker, J. W., Cameron, P. M., Zaller, D. M., Pikounis, V. B., O’Keefe, S. J., & Scapin, G. (2003) · Nature Structural & Molecular Biology · doi:10.1038/nsb949 · Cited by 182

The Structure-Based Design of ATP-Site Directed Protein Kinase Inhibitors

Toledo, L. M., LYDON, N. B., & Elbaum, D. (1999) · Current Medicinal Chemistry · doi:10.2174/092986730609220401150028 · Cited by 177

Developmental expression in the mouse nervous system of the p493F12 SAP kinase

Martin, J. H., Mohit, A. A., & Miller, C. A. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00181-q · Cited by 137

Structural biology in drug design: selective protein kinase inhibitors

Scapin, G. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02290-0 · Cited by 109

Structure-based design of cyclin-dependent kinase inhibitors

Davies, T. G., Pratt, D. J., Endicott, J., Johnson, L. N., & Noble, M. E. M. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00182-1 · Cited by 97

Molecular Basis for p38 Protein Kinase Inhibitor Specificity

Lisnock, J., Tebben, A., Frantz, B., O’Neill, E. A., Croft, G. F., O’Keefe, S. J., Li, B., Hacker, C., de Laszlo, S. E., Smith, A. J., et al. (1998) · Biochemistry · doi:10.1021/bi981591x · Cited by 95

New inhibitors of p38 kinase

Boehm, J. C., & Adams, J. L. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.1.25 · Cited by 80

Activation of JNK3α1 Requires both MKK4 and MKK7: Kinetic Characterization of in Vitro Phosphorylated JNK3α1

Lisnock, J., Griffin, P., Calaycay, J., Frantz, B., Parsons, J., O'Keefe, S. J., & LoGrasso, P. (2000) · Biochemistry · doi:10.1021/bi992410+ · Cited by 79

Protein kinase inhibitors: emerging pharmacophores 1997 - 2000

Dumas, J. (2001) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.11.3.405 · Cited by 71

Protein kinase inhibitors: structural determinants for target specificity.

McMahon, G., Sun, L., Liang, C., & Tang, C. (1998) · PubMed · Cited by 32

Inhibitors of the JNK signaling pathway

Harper, S. J., & Lo Grasso, P. (2001) · Drugs of the Future · doi:10.1358/dof.2001.026.10.858715 · Cited by 13

Protein kinase antagonists: interim challenges and issues.

Ea, S. (2000) · PubMed · Cited by 11

Protein Kinase Inhibitors

Kleemann, A. (2014) · Ullmann's Encyclopedia of Industrial Chemistry · doi:10.1002/14356007.r22_r01 · Cited by 2

Protein Kinase Antagonists

Laurence, A. D. J., Gadina, M., Schwartzberg, P. L., & O’Shea, J. J. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8165-1.00085-x · Cited by 1

Untitled work

Rinehart (2000) · doi:10.1002/(sici)1098-1128(200001)20:1

Diverse, High-Quality Test Set for the Validation of Protein−Ligand Docking Performance

Hartshorn, M. J., Verdonk, M. L., Chessari, G., Brewerton, S. C., Mooij, W. T. M., Mortenson, P. N., & Murray, C. W. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061277y · Cited by 639

Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal Kinases

Bogoyevitch, M. A., & Kobe, B. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00025-06 · Cited by 584

Halogen Bonding—A Novel Interaction for Rational Drug Design?

Lu, Y., Shi, T., Wang, Y., Yang, H., Yan, X., Luo, X., Jiang, H., & Zhu, W. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9000133 · Cited by 562

Through the “Gatekeeper Door”: Exploiting the Active Kinase Conformation

Zuccotto, F., Ardini, E., Casale, E., & Angiolini, M. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901443h · Cited by 560

c-Jun N-terminal kinase (JNK) signaling: Recent advances and challenges

Bogoyevitch, M. A., Ngoei, K. R. W., Zhao, T. T., Yeap, Y. Y. C., & Ng, D. C. H. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.11.002 · Cited by 335

Explaining Isoform Selectivity of c-Jun N-Terminal Kinase 3 (JNK3) Inhibitors through Its Development and Structural Insights

Yu, H., Zhang, X., Liu, Z., & Zhang, L. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01488 · Cited by 4

Fragment-Based and Structural Investigation for Discovery of JNK3 Inhibitors

Duong, M. T. H., & Ahn, H. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14091900 · Cited by 4

C-Jun N-terminal kinase inhibitors: Structural insight into kinase-inhibitor complexes

Duong, M. T. H., Lee, J., & Ahn, H. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.06.013 · Cited by 34

Insight into the selective inhibition of JNK family members through structure-based drug design

Messoussi, A., Chevé, G., Bougrin, K., & Yasri, A. (2016) · MedChemComm · doi:10.1039/c5md00562k · Cited by 3

N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3

Angell, R. M., Atkinson, F. L., Brown, M. J. B., Chuang, T. T., Christopher, J. A., Cichy-Knight, M. A., Dunn, A. K., Hightower, K. E., Malkakorpi, S., Musgrave, J. R., et al. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.12.003 · Cited by 95